ID

29868

Descrizione

Study ID: 104864-201 Clinical Study ID: 104864/A201 Study Title: A Phase III, Open-Label, Multicenter, Randomized, Comparative Study of Topotecan, Ara-C and G-CSF (TAG) versus Idarubicin, Ara-C and G-CSF (IDAG) in MDS Patients with RAEB (High-Risk), RAEB-t or in Patients with AML from a Preceding Phase of MDS Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: hycamtin Study Indication: Myelodysplastic Syndrome https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

collegamento

https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs

Keywords

versioni (1)
  1. 24/04/18 24/04/18 - Halim Ugurlu
Titolare del copyright

GSK

Caricato su

24 aprile 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

GSK Study ID 104864-201 Serious Adverse Experience

Inglese

Serious Adverse Experience (SAE)

1 moduli  
Identification Numbers
Descrizione

Identification Numbers

Alias
UMLS CUI-1
C1300638
Center Number
Descrizione

Center Number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Patient Number
Descrizione

Patient Number

Tipo di dati

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Descrizione

Patient Initials

Tipo di dati

text

Alias
UMLS CUI [1]
C2986440
Serious Adverse Experience (SAE)
Descrizione

Serious Adverse Experience (SAE)

Alias
UMLS CUI-1
C1519255
Person Reporting SAE (Please print clearly)
Descrizione

Person Reporting SAE

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0335038
UMLS CUI [1,2]
C1519255
Serious Adverse Experience
Descrizione

Serious Adverse Experience

Tipo di dati

text

Alias
UMLS CUI [1]
C1519255
Specify reason(s) for considering this a serious AE. Mark all that apply.
Descrizione

Reason(s) for considering this a serious AE

Tipo di dati

text

Alias
UMLS CUI [1]
C3828190
Onset Data and Time
Descrizione

Onset Data and Time

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0040223
End Date and Time (if ongoing please leave blank)
Descrizione

End Date and Time (if ongoing please leave blank)

Tipo di dati

datetime

Alias
UMLS CUI [1]
C2981425
Outcome- If patient died, please complete Form D
Descrizione

Outcome

Tipo di dati

text

Alias
UMLS CUI [1]
C1705586
Experience Course
Descrizione

Experience Course

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Common Toxicity Grade: 1-4
Descrizione

Common Toxicity Grade

Tipo di dati

text

Alias
UMLS CUI [1]
C2826262
Action Taken with Respect to Investigational Drug
Descrizione

Action Taken with Respect to Investigational Drug

Tipo di dati

text

Alias
UMLS CUI [1]
C2826626
Did the SAE abate?
Descrizione

SAE Abate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C3853704
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)
Descrizione

Study medication reintroduced

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3854006
UMLS CUI [1,2]
C0580673
If Yes to study medication reintroduced (or dose increased), did SAE recur?
Descrizione

If Yes to study medication reintroduced (or dose increased)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0034897
Relationship to Investigational Drug
Descrizione

Relationship to Investigational Drug

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0439849
UMLS CUI [1,2]
C3854006
What is the SAE probably associated with ?
Descrizione

Assessment of SAE

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1710056
If ´Yes´ record details in the Concomitant Medication section
Descrizione

Corrective Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was patient withdrawn due to this specific SAE?
Descrizione

Withdrawn due to this specific SAE

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1519255
Relevant Laboratory Data-Test name
Descrizione

Relevant Laboratory Data - Please provide relevant abnormal laboratory data below

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0027365
Relevant Laboratory Data - Date
Descrizione

Relevant Laboratory Data-Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0011008
Relevant Laboratory Data-Value
Descrizione

Relevant Laboratory Data-Value

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0587081
Relevant Laboratory Data-Units
Descrizione

Relevant Laboratory Data-Units

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C1519795
Relevant Laboratory Data-Normal Range
Descrizione

Relevant Laboratory Data-Normal Range

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0086715
Relevant Laboratory Data-Remarks
Descrizione

Remarks (Please provide a brief narrative description of the SAE, attaching extra pages eg. hospital discharge summary if necessary)

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0587081
UMLS CUI [1,2]
C1519255
UMLS CUI [1,3]
C0947611
Additional Informations
Descrizione

Additional Informations

Alias
UMLS CUI-1
C1546922
If applicable, was randomisation code broken at investigational site ?
Descrizione

Randomisation code broken at investigational site

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C1272691
UMLS CUI [1,3]
C2825164
Randomisation/Study Medication Number
Descrizione

Randomisation/Study Medication Number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Investigators Signature
Descrizione

Investigators Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Investigators Signature Date
Descrizione

Investigators Signature Date

Tipo di dati

date

Alias
UMLS CUI [1]
C0807937
Please PRINT name
Descrizione

Please PRINT name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892
Ritorna all'inizio della pagina

Similar models

Serious Adverse Experience (SAE)

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Identification Numbers
C1300638 (UMLS CUI-1)
Center Number
Item
Center Number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Serious Adverse Experience (SAE)
C1519255 (UMLS CUI-1)
Person Reporting SAE
Item
Person Reporting SAE (Please print clearly)
text
C0335038 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Serious Adverse Experience
Item
Serious Adverse Experience
text
C1519255 (UMLS CUI [1])
Item
Specify reason(s) for considering this a serious AE. Mark all that apply.
text
C3828190 (UMLS CUI [1])
Specify reason(s) for considering this a serious AE. Mark all that apply.
Code List
Specify reason(s) for considering this a serious AE. Mark all that apply.
CL Item
fatal  (1)
CL Item
life threatening  (2)
CL Item
disabling/incapacitating  (3)
CL Item
results in hospitalization (excluding elective surgery or routine clinical procedures)  (4)
CL Item
hospitalization prolonged  (5)
CL Item
congenital abnormality  (6)
CL Item
cancer  (7)
CL Item
overdose  (8)
CL Item
Investigator considers serious or a significant hazard, contraindication, side effect or precaution (9)
Onset Data and Time
Item
Onset Data and Time
datetime
C0011008 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
End Date and Time (if ongoing please leave blank)
Item
End Date and Time (if ongoing please leave blank)
datetime
C2981425 (UMLS CUI [1])
Item
Outcome- If patient died, please complete Form D
text
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome- If patient died, please complete Form D
CL Item
Resolved (1)
CL Item
Ongoing (2)
CL Item
Died (3)
Item
Experience Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Experience Course
Code List
Experience Course
CL Item
Intermittent (number of episodes:..............) (1)
CL Item
Constant (2)
Common Toxicity Grade
Item
Common Toxicity Grade: 1-4
text
C2826262 (UMLS CUI [1])
Item
Action Taken with Respect to Investigational Drug
text
C2826626 (UMLS CUI [1])
Action Taken with Respect to Investigational Drug
Code List
Action Taken with Respect to Investigational Drug
CL Item
None (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Drug stopped (4)
CL Item
Drug interrupted/restarted (5)
CL Item
Dose delayed (6)
CL Item
Dose delayed and decreased (7)
SAE Abate
Item
Did the SAE abate?
boolean
C1519255 (UMLS CUI [1,1])
C3853704 (UMLS CUI [1,2])
Study medication reintroduced
Item
If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)
boolean
C3854006 (UMLS CUI [1,1])
C0580673 (UMLS CUI [1,2])
If Yes to study medication reintroduced (or dose increased)
Item
If Yes to study medication reintroduced (or dose increased), did SAE recur?
boolean
C1519255 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
Item
Relationship to Investigational Drug
text
C0439849 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Relationship to Investigational Drug
Code List
Relationship to Investigational Drug
CL Item
Not related (4)
CL Item
Unlikely (3)
CL Item
Suspected (reasonable possibility) (2)
CL Item
Probable (1)
Item
What is the SAE probably associated with ?
text
C0085978 (UMLS CUI [1,1])
C1710056 (UMLS CUI [1,2])
Assessment of SAE
Code List
What is the SAE probably associated with ?
CL Item
Protocol design or procedures (but not to study drug) -Please specify:....................... (1)
CL Item
Another Condition (eg, condition under study, intercurrent illness) -Please specify:....................... (2)
CL Item
Another Drug -Please specify:....................... (3)
Corrective Therapy
Item
If ´Yes´ record details in the Concomitant Medication section
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Withdrawn due to this specific SAE
Item
Was patient withdrawn due to this specific SAE?
boolean
C0422727 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Relevant Laboratory Data-Test name
Item
Relevant Laboratory Data-Test name
text
C0022885 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Relevant Laboratory Data-Date
Item
Relevant Laboratory Data - Date
date
C0022885 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Relevant Laboratory Data-Value
Item
Relevant Laboratory Data-Value
text
C0022885 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Relevant Laboratory Data-Units
Item
Relevant Laboratory Data-Units
text
C0022885 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Relevant Laboratory Data-Normal Range
Item
Relevant Laboratory Data-Normal Range
text
C0022885 (UMLS CUI [1,1])
C0086715 (UMLS CUI [1,2])
Relevant Laboratory Data-Remarks
Item
Relevant Laboratory Data-Remarks
text
C0587081 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Item Group
Additional Informations
C1546922 (UMLS CUI-1)
Randomisation code broken at investigational site
Item
If applicable, was randomisation code broken at investigational site ?
boolean
C0034656 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C2825164 (UMLS CUI [1,3])
Randomisation/Study Medication Number
Item
Randomisation/Study Medication Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Investigators Signature
Item
Investigators Signature
text
C2346576 (UMLS CUI [1])
Investigators Signature Date
Item
Investigators Signature Date
date
C0807937 (UMLS CUI [1])
Please PRINT name
Item
Please PRINT name
text
C2826892 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial